| Medication | Prior to presentation; no. (%) of patients | At time of discharge;* no. (%) of patients | At 90 d post-MI;† no. (%) of patients |
|---|---|---|---|
| n = 2181 | n = 2043 | n = 1839 | |
| ACE + ARB inhibitor | 636 (29.2) | 1740 (85.2) | 1431 (77.8) |
| Statin | 552 (25.3) | 1878 (91.9) | 1585 (86.2) |
| ASA | 445 (20.4) | 1957 (95.8) | 1622 (88.2) |
| ACE inhibitor | 435 (19.9) | 1622 (79.4) | 1308 (71.1) |
| β-Blocker | 343 (15.7) | 1743 (85.3) | 1396 (75.9) |
| ARB inhibitor | 215 (9.9) | 125 (6.1) | 143 (7.8) |
| Clopidogrel | 106 (4.9) | 1688 (82.6) | 1415 (76.9) |
| Warfarin | 43 (2.0) | 133 (6.5) | 94 (5.1) |
Note: ACE = angiotensin-converting-enzyme, ARB = angiotensin II receptor blocker, ASA = acetylsalicylic acid, MI = myocardial infarction. *Data exclude patients who died prior to treatment and those already admitted when the STEMI occurred. †Data exclude patients who died or were lost to follow-up.